On April 25, 2022 INmune Bio (NASDAQ: INMB), a clinical stage immunology company focused on developing treatments that harness the patient’s immune system to fight disease, reported that management will participate at the B. Riley Neuro & Ophthalmology Conference which is being held virtually on April 28, 2022 (Press release, INmune Bio, APR 25, 2022, View Source [SID1234612939]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

B. Riley Neuro & Ophthalmology Conference

RJ Tesi, MD., President and CEO will participate in a fireside chat at the B. Riley Neuro & Ophthalmology Conference which is being held virtually on April 28, 2022.

The conference is by invitation-only with attendance reserved for B. Riley Securities’ institutional clients. Interested attendees should contact their B. Riley Securities representative to inquire about an invitation.